Table 2 Characteristic of studies using PCR or IHC
From: Chlamydia pneumoniae infection and cerebrovascular disease: a systematic review and meta-analysis
Author Y | Country | Study design | Number of case/control | Case assessment | Detecting assay | Specimen | Odds ratio (95% CI) |
|---|---|---|---|---|---|---|---|
Gagliardi RJ 2009 | Brazil | CSCC | 52/59 | Ischemic stroke, TIA | PCR | PBMC/DNA | 0.37(0.01 ~ 9.32) |
Kis Z 2007 | Hungary | CSCC | 59/52 | Ischemic stroke | PCR | PBMC/DNA | 1.92(0.61 ~ 6.01) |
Apfalter P 2004 | Australia | CSCC | 45/30 | Stroke, TIA | PCR | PBMC/DNA | 0.65(0.09 ~ 4.89) |
Wang SL 2003 | China | CSCC | 93/90 | Ischemic storke | PCR | PBMC/DNA | 2.29(1.26 ~ 4.13) |
Müller J 2003 | Denmark | CSCC | 193/368 | Stroke | PCR | PBMC/DNA | 1.35(0.74 ~ 2.46) |
Sessa R 2003 | Italy | CSCC | 18/33 | Ischemic stroke,TIA | PCR | PBMC/DNA | 5.98(1.68 ~ 21.31) |
Wohlschlaeger J 2005 | German | CSCC | 9/23 | Ischemic stroke | PCR | Carotid plaque/DNA | 2.75(0.15 ~ 49.36) |
Sessa R 2003 | Italy | CSCC | 18/33 | Ischemic stroke,TIA | PCR | Carotid plaque/DNA | 1.84(0.56 ~ 6.05) |
Katsenis C 2001 | Greece | CSCC | 20/15 | Sympotomatic carotid disease | PCR | Carotid plaque/DNA | 4.19(0.19 ~ 93.97) |
LaBiche R 2001 | USA | CSCC | 37/57 | Sympotomatic carotid disease | PCR | Carotid plaque/DNA | 0.83(0.26 ~ 2.72) |
Wohlschlaeger J 2005 | German | CSCC | 9/23 | Ischemic stroke | IHC | Carotid plaque | 0.14(0.01 ~ 1.27) |
Lastas A 2004 | Lithuania | CSCC | 141/59 | Sympotomatic carotid disease | IHC | Carotid plaque | 0.88(0.33 ~ 2.38) |
Neureiter D 2003 | German | CSCC | 20/40 | Ischemic stroke | IHC | Carotid plaque | 9.0(2.32 ~ 34.88) |
Jahromi BS 2003 | Canada | CSCC | 57/13 | Stoke,TIA | IHC | Carotid plaque | 0.6(0.18 ~ 2.07) |